Document Classification

Section Type: RESULTS

Text: Treatment with inhaled nitric oxide and placebo did not result in significant differences in survival of infants without development of bronchopulmonary dysplasia (258 [65 %] of 395 vs 262 [66 %] of 400, respectively ; relative risk 1. 05, 95 % CI 0. 78-1. 43) ; in survival at 36 weeks'postmenstrual age (343 [86 %) of 399 vs 359 [90 %] of 401, respectively ; 0. 74, 0. 48-1. 15) ; and in development of bronchopulmonary dysplasia (81 [24 %] of 339 vs 96 [27 %] of 358, respectively ; 0. 83, 0. 58-1. 17).